- Filed
- Mar 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 15.95K sh |
| Capex | FY 2024 · Dec 31, 2023 | $10.15M |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$137.17M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $87.1M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $15.4M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $45.87M |
| Current Assets | FY 2024 · Dec 31, 2023 | $92.14M |
| Total Assets | FY 2024 · Dec 31, 2023 | $92.17M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$21.67 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$21.67 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $54.41M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $33.34M |
| Net Income | FY 2024 · Dec 31, 2023 | −$343.07M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$348.9M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $91.55M |
| Revenue | FY 2024 · Dec 31, 2023 | $2.34M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $351.77M |